Pemafibrate (Parmodia)

Ongoing Trials

Efficacy and safety of pemafibrate for nonalcoholic fatty liver disease (PRESENT, NCT06623539)
Study to evaluate the efficacy and safety of pemafibrate in primary biliary cholangitis (PBC) (NCT06247735)

Completed Trials

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Recordati

Recordati

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Sobi

Sobi